Hennion & Walsh Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
AAS
RP
VF
LTAS
CCG
ORI
NFG
PCM
Hennion & Walsh Asset Management's LMAT Position: Q2 2026 in Review
Hennion & Walsh Asset Management reduced its LeMaitre Vascular (LMAT) stake by 7.4% in Q2 2026, selling an estimated $121K and leaving 14,825 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #475.
Hennion & Walsh Asset Management first reported a position in LMAT in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.38M in Q3 2025. 63 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Hennion & Walsh Asset Management held 14,825 shares of LeMaitre Vascular worth $1.42M as of Q2 2026.
- Hennion & Walsh Asset Management sold 1,179 LeMaitre Vascular shares in Q2 2026, an estimated $121K.
- LeMaitre Vascular made up 0.04% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #475 holding.
- Hennion & Walsh Asset Management first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 18 quarters since.
- Hennion & Walsh Asset Management's LeMaitre Vascular position peaked at $2.38M in Q3 2025.
- 63 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.